Skip to content
Screener

Bristol-Myers Squibb BMY Q1 2026 earnings

Reported April 30, 2026 · Before market open

Revenue$11.5BBeat by $561.6M
EPS$1.58Beat by $0.16
Revenue estimate$10.9B
EPS estimate$1.42
“We are off to a good start in 2026, with first quarter results reflecting sustained momentum across our Growth Portfolio and disciplined execution throughout the business, With multiple pivotal data readouts and opportunities ahead, we remain focused on advancing our differentiated pipeline and translating this progress into meaningful outcomes for patients and shareholders.”
Christopher Boerner

Next report

Oct 29, 2026 (In 3 weeks)
Revenue estimate$12.6B
EPS estimate$1.68

Financials

Q1 2026

Income statement

See full
Revenue$11.5B+2.6%
Gross profit$8.1B-1.2%
Net income$2.7B+9.0%
EPS (diluted)$1.31+9.2%

Balance sheet

See full
Cash & equivalents$9.6B-12.0%
Total debt$44.7B-10.5%
Total equity$20.1B+15.4%
Total assets$86.5B-6.4%

Cash flow

See full
Operating cash flow$1.1B-43.5%
CapEx$347.0M+33.5%
Free cash flow$757.0M-55.3%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$123.83B-0.2%
Enterprise value$158.92B-2.6%
P/E17×-6.2×
P/S2.6×-0.1×

Profitability

See full
Gross margin70.5%0.0pp
Net margin15%+3.8pp
FCF margin24.6%-2.9pp

Returns & leverage

See full
Return on equity38.8%+7.3pp
Debt / equity2.2×-0.6×
Current ratio1.4×+0.1×

Segments

By product

See full
Eliquis$4.1B+16.0%
Opdivo$2.1B-5.3%
Orencia$818.0M+6.2%
Yervoy$651.0M+4.3%
Other Growth products$581.0M+44.2%

By geography

See full
International$3.4B—
Other$257.0M+17.9%

FAQ

When did Bristol-Myers Squibb report Q1 2026 earnings?
Bristol-Myers Squibb (BMY) reported Q1 2026 earnings on April 30, 2026 before market open.
What were Bristol-Myers Squibb's Q1 2026 revenue and EPS?
Bristol-Myers Squibb reported revenue of $11.5B and eps of $1.58 for Q1 2026.
Did Bristol-Myers Squibb beat estimates in Q1 2026?
Revenue beat the consensus estimate of $10.9B by $561.6M. EPS beat the consensus estimate of $1.42 by $0.16.
How did Bristol-Myers Squibb's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.6% from $11.2B a year earlier and eps declined 12.2% from $1.80.
Where can I find Bristol-Myers Squibb's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000014272-26-000008) and the 10-Q periodic report (0000014272-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.